These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36324493)

  • 1. Current leishmaniasis drug discovery.
    Pinheiro AC; de Souza MVN
    RSC Med Chem; 2022 Sep; 13(9):1029-1043. PubMed ID: 36324493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis.
    Tiwari N; Gedda MR; Tiwari VK; Singh SP; Singh RK
    Mini Rev Med Chem; 2018; 18(1):26-41. PubMed ID: 28443518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying vaccine targets for anti-leishmanial vaccine development.
    Sundar S; Singh B
    Expert Rev Vaccines; 2014 Apr; 13(4):489-505. PubMed ID: 24606556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host.
    Singh R; Kashif M; Srivastava P; Manna PP
    Pathogens; 2023 May; 12(5):. PubMed ID: 37242374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmaniasis: current status of available drugs and new potential drug targets.
    Singh N; Kumar M; Singh RK
    Asian Pac J Trop Med; 2012 Jun; 5(6):485-97. PubMed ID: 22575984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational new drugs for the treatment of leishmaniasis.
    Sundar S; Singh VK; Agrawal N; Singh OP; Kumar R
    Expert Opin Investig Drugs; 2024 Oct; 33(10):1029-1046. PubMed ID: 39225742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties.
    Corman HN; Ross JN; Fields FR; Shoue DA; McDowell MA; Lee SW
    Microbiol Spectr; 2022 Dec; 10(6):e0265822. PubMed ID: 36342284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative to Chemotherapy-The Unmet Demand against Leishmaniasis.
    Didwania N; Shadab M; Sabur A; Ali N
    Front Immunol; 2017; 8():1779. PubMed ID: 29312309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches to discover marine antileishmanial natural products.
    Tempone AG; Martins de Oliveira C; Berlinck RG
    Planta Med; 2011 Apr; 77(6):572-85. PubMed ID: 21243582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?
    Freitas-Junior LH; Chatelain E; Kim HA; Siqueira-Neto JL
    Int J Parasitol Drugs Drug Resist; 2012 Dec; 2():11-9. PubMed ID: 24533267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral leishmaniasis: advances in treatment.
    Maltezou HC
    Recent Pat Antiinfect Drug Discov; 2008 Nov; 3(3):192-8. PubMed ID: 18991801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance in visceral leishmaniasis.
    Maltezou HC
    J Biomed Biotechnol; 2010; 2010():617521. PubMed ID: 19888437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileishmanial patents antileishmanial current drugs and relevant patents.
    Monzote L
    Recent Pat Antiinfect Drug Discov; 2011 Jan; 6(1):1-26. PubMed ID: 21192776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.
    Charlton RL; Rossi-Bergmann B; Denny PW; Steel PG
    Parasitology; 2018 Feb; 145(2):219-236. PubMed ID: 28805165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmaniasis: current treatment and prospects for new drugs and vaccines.
    Kedzierski L; Sakthianandeswaren A; Curtis JM; Andrews PC; Junk PC; Kedzierska K
    Curr Med Chem; 2009; 16(5):599-614. PubMed ID: 19199925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets.
    Altamura F; Rajesh R; Catta-Preta CMC; Moretti NS; Cestari I
    Drug Dev Res; 2022 Apr; 83(2):225-252. PubMed ID: 32249457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileishmanial Activity of Lignans, Neolignans, and Other Plant Phenols.
    Pospíšil J; Konrádová D; Strnad M
    Prog Chem Org Nat Prod; 2021; 115():115-176. PubMed ID: 33797642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural product based leads to fight against leishmaniasis.
    Singh N; Mishra BB; Bajpai S; Singh RK; Tiwari VK
    Bioorg Med Chem; 2014 Jan; 22(1):18-45. PubMed ID: 24355247
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.